Another scientific journey, published. After years of receiving each others emails & being confused for one another at MDS meetings @eirinipapapetr1 &I decided to join forces to study SF3B1 mutated MDS.

Excited to present today with Dylan Domenico our workflow on interpretable classification of genomic variants in whole genome sequencing from archived tissue. If you're in Hawaii, come check out our work at the ICML-Compbio-Workshop Paper Online: icml-compbio.github.io/2023/papers/WC… #ICML2023

A very warm thank you to everyone who has been part of this journey - really motivated for the chapters ahead!

Thank you Elli Papaemmanuil, PhD! Great to be working with you and everyone in the lab.

.Michael Berger, David B. Solit, MD, Marc Ladanyi, and the MSK-Impact team accept the AACR Team Science Award for developing and implementing a groundbreaking next-generation sequencing platform which has enabled the comprehensive molecular characterization of over 125,000 tumors. #AACR25

Congratulations to Memorial Sloan Kettering Cancer Center MSK-IMPACT team and OncoKB™ for receiving the #AACR25 TEAM Science Award! The impact of this team, assay & data to our understanding of cancer biology is unprecedented.

At #AACR25, stop by Kevin Boehm's poster to learn about his work training an artificial intelligence model to predict genetic changes in tumors by analyzing slide images. Memorial Sloan Kettering Cancer Center AACR Learn more: bit.ly/3YJBO9i

Very glad to be presenting today at #AACR our work from the Elli Papaemmanuil, PhD on integrating multimodal data in Myeloid Neoplasms. Looking forward to an exciting poster session!

We're wrapping up #AACR25 on a strong note! Swing by the Exhibit Hall from now until 12pm CT to learn from our MSK experts and their work in clinical research and #cancer prevention. AACR

Online First: Multi-Modal and Data-Driven Assessment of Myeloid Neoplasms Refines Classification Across Disease States brnw.ch/21wTSQI